id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-2136-0006,FDA,FDA-2022-E-2136,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2024-01-19T05:00:00Z,2024,1,2024-01-19T05:00:00Z,,2024-01-19T13:00:39Z,,0,0,09000064863a94be
FDA-2022-E-2136-0005,FDA,FDA-2022-E-2136,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-01-11T05:00:00Z,2024,1,2024-01-11T05:00:00Z,,2024-01-11T21:26:10Z,,0,0,090000648638f1ef